<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04700202</url>
  </required_header>
  <id_info>
    <org_study_id>046.PHA.2020.D</org_study_id>
    <nct_id>NCT04700202</nct_id>
  </id_info>
  <brief_title>Identifying Risk Factors for Gram-negative Resistance for HAP/VAP in the Intensive Care Unit</brief_title>
  <official_title>Identifying Risk Factors for Gram-negative Resistance for HAP/VAP in the Intensive Care Unit</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Methodist Health System</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Methodist Health System</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Single center, retrospective chart review. Patients admitted to MDMC ICU from 4/1/2017 to&#xD;
      6/30/2020 will be identified through the electronic medical record utilizing ICD codes for&#xD;
      HAP and VAP.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Single center, retrospective chart review. Patients admitted to MDMC ICU from 4/1/2017 to&#xD;
      6/30/2020 will be identified through the electronic medical record utilizing ICD codes for&#xD;
      HAP and VAP. Patients with respiratory culture data signifying a Gram-negative organism as&#xD;
      the cause of HAP/VAP will be analyzed as described below if study inclusion criteria is met.&#xD;
      Minimum inhibitory concentration (MIC) data will interpreted per Clinical &amp; Laboratory&#xD;
      Standards Institute (CLSI) standards to determine local patterns of resistance. Multivariable&#xD;
      logistic regression will be performed to determine risk factors for piperacillin-tazobactam,&#xD;
      cefepime or meropenem resistant Gram-negative isolates. Project target date of completion and&#xD;
      close-out is May 2021.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 30, 2020</start_date>
  <completion_date type="Anticipated">June 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">May 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of Gram-negative isolate resistance to piperacillin-tazobactam, cefepime, meropenem</measure>
    <time_frame>April 2017 - May 2020</time_frame>
    <description>Percentage</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of susceptibility to non-beta lactam antipseudomonal agents</measure>
    <time_frame>April 2017 - May 2020</time_frame>
    <description>Percentage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>in-hospital mortality</measure>
    <time_frame>April 2017 - May 2020</time_frame>
    <description>Percentage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>need for mechanical ventilation</measure>
    <time_frame>April 2017 - May 2020</time_frame>
    <description>Percentage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>duration of mechanical ventilation</measure>
    <time_frame>April 2017 - May 2020</time_frame>
    <description>number of days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>development of septic shock</measure>
    <time_frame>April 2017 - May 2020</time_frame>
    <description>Percentage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU length of stay</measure>
    <time_frame>April 2017 - May 2020</time_frame>
    <description>number of days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hospital length of stay</measure>
    <time_frame>April 2017 - May 2020</time_frame>
    <description>number of days</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Ventilator-associated Pneumonia</condition>
  <condition>Hospital-acquired Pneumonia</condition>
  <arm_group>
    <arm_group_label>Retrospective Cohort</arm_group_label>
    <description>Patients admitted to MDMC ICU from 4/1/2017 to 6/30/2020 will be identified through the electronic medical record utilizing ICD codes for HAP and VAP.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Observational</intervention_name>
    <description>Single center, retrospective chart review. Patients admitted to MDMC ICU from 4/1/2017 to 6/30/2020 will be identified through the electronic medical record utilizing ICD codes for HAP and VAP</description>
    <arm_group_label>Retrospective Cohort</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients admitted to MDMC ICU from 4/1/2017 to 6/30/2020 will be identified through the&#xD;
        electronic medical record utilizing ICD codes for HAP and VAP.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ICU, Neuro critical care unit admission&#xD;
&#xD;
          -  Diagnosis of HAP or VAP&#xD;
&#xD;
          -  Respiratory culture positive for Gram-negative organism&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  ICU length of stay &lt;48 hours prior to HAP/VAP&#xD;
&#xD;
          -  Culture or MIC data unavailable&#xD;
&#xD;
          -  Pregnant&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Matthew Crotty, PharmD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Methodist Health System</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Crystee Cooper, DHEd</last_name>
    <phone>214-947-1280</phone>
    <email>ClinicalResearch@mhd.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tammy Chan, PhD</last_name>
    <phone>214-947-1280</phone>
    <email>ClinicalResearch@mhd.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Methodist Dallas Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthew Crotty, PharmD</last_name>
      <phone>214-941-2400</phone>
      <email>matthewcrotty@mhd.com</email>
    </contact>
    <investigator>
      <last_name>Matthew Crotty, PharmD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 22, 2020</study_first_submitted>
  <study_first_submitted_qc>January 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 7, 2021</study_first_posted>
  <last_update_submitted>January 6, 2021</last_update_submitted>
  <last_update_submitted_qc>January 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Pneumonia, Ventilator-Associated</mesh_term>
    <mesh_term>Healthcare-Associated Pneumonia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

